StocksN › NAVB

Navidea Biopharmaceuticals, Inc. (NAVB) — Earnings Call X-Ray

Our AI read all 26 of NAVB's earnings calls (2016–2023) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q4 2022 · sign up to see
Previous Call Grade
F
Q3 2022
Expected Move
🔒
next 45 days · members
Calls Analyzed
26
2016–2023
Avg Candor
5.6/9
evasion 4.3/9
Promotional ToneCritic AmmunitionUnderused Fixed CostsMargins ContractingReads RehearsedQuestion Left HangingResults Worse Than Direction

Call-by-call analysis

🔒 Q4 2022 earnings call 2023-03-21 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q4 2022 call grade is ready
The full 37-point AI read of NAVB's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

F Q3 2022 earnings call 2022-11-15

Management gave no formal guidance against steady demand and contracting margins. The delivery was promotional in tone.

Demand: stableMargins: contractingHeadcount: growing 2 analysts · 6 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedDirection beats results
Candor 5/9
Specificity 6/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 8/9
Stress 3/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q2 2022 earnings call 2022-09-08

Management held guidance steady against contracting margins. The delivery was rich in specifics, frequently evasive, visibly under pressure.

Guidance: maintainedMargins: contractingPricing: stableHeadcount: flat 4 analysts · 15 questions
⚑ Critic ammunition⚑ Question left hangingDirection beats results
Candor 5/9
Specificity 7/9
Evasion 6/9
Confidence 7/9
Uncertainty 6/9
Promotion 7/9
Stress 6/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q1 2022 earnings call 2022-05-12

Management gave no formal guidance. The delivery was rich in specifics, promotional in tone.

4 analysts · 17 questions
⚑ Critic ammunition⚑ Question left hangingDirection beats results
Candor 6/9
Specificity 7/9
Evasion 5/9
Confidence 7/9
Uncertainty 6/9
Promotion 7/9
Stress 5/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q4 2021 earnings call 2022-03-23

Management gave no formal guidance against contracting margins. The delivery was frequently evasive.

Margins: contractingHeadcount: flat 3 analysts · 16 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedDirection beats results
Candor 5/9
Specificity 6/9
Evasion 6/9
Confidence 6/9
Uncertainty 5/9
Promotion 6/9
Stress 4/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q3 2021 earnings call 2021-11-11

Management gave no formal guidance against contracting margins. The delivery was promotional in tone.

Margins: contracting 1 analysts · 22 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedDirection beats results
Candor 5/9
Specificity 6/9
Evasion 4/9
Confidence 7/9
Uncertainty 6/9
Promotion 7/9
Stress 5/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q2 2021 earnings call 2021-08-11

Management gave no formal guidance against contracting margins. The delivery was rich in specifics, promotional in tone.

Margins: contractingPricing: under pressureHeadcount: growing 3 analysts · 12 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up aheadDirection beats results
Candor 6/9
Specificity 7/9
Evasion 5/9
Confidence 8/9
Uncertainty 4/9
Promotion 8/9
Stress 3/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q1 2021 earnings call 2021-05-11

Management gave no formal guidance against contracting margins. The delivery was rich in specifics, promotional in tone.

Margins: contractingHeadcount: flatCapex: increasing 3 analysts · 11 questions
⚑ Critic ammunition⚑ Question left hanging✓ Resolves doubtsDirection beats results
Candor 6/9
Specificity 7/9
Evasion 4/9
Confidence 8/9
Uncertainty 5/9
Promotion 8/9
Stress 3/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q4 2020 2021-03-25 F noneunclearcontracting 4/9 5/9
Q3 2020 2020-11-12 D noneunclearcontracting 6/9 3/9
Q2 2020 2020-08-14 F noneunclearunclear 6/9 3/9
Q1 2020 2020-05-14 F noneunclearcontracting 5/9 6/9
Q4 2019 2020-03-12 F noneacceleratingunclear 6/9 4/9
Q3 2019 2019-11-09 F noneunclearcontracting 5/9 4/9
Q2 2019 2019-08-08 D noneacceleratingcontracting 6/9 2/9
Q1 2019 2019-05-08 F noneunclearcontracting 5/9 4/9
Q4 2018 2019-03-07 D noneunclearcontracting 7/9 3/9
Q3 2018 2018-11-07 F noneunclearcontracting 4/9 5/9
Q2 2018 2018-08-16 F noneunclearexpanding 6/9 3/9
Q1 2018 2018-05-09 F noneunclearcontracting 6/9 5/9
Q4 2017 2018-03-08 D noneunclearcontracting 8/9 3/9
Q3 2017 2017-11-08 F noneunclearcontracting 5/9 4/9
Q3 2016 2016-11-03 F noneacceleratingexpanding 6/9 5/9
Q2 2016 2016-08-05 F noneacceleratingexpanding 6/9 4/9
Q1 2016 2016-05-17 F maintainedacceleratingstable 4/9 5/9
Q4 2015 2016-03-24 F maintainedacceleratingstable 6/9 4/9

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAMC · Altisource Asset ManagemAAON · AAON, Inc.AASZF · Atlantic Sapphire ASAAAT · American Assets Trust, IABCD · Cambium Learning Group'sABCO · The Advisory Board

NAV   All “N” companies    NAVG

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.